Others

  • HOME
  • ARTICLE CATEGORY
  • Others
Erratum
Erratum to ‘Genomic biomarkers to predict response to atezolizumab plus bevacizumab immunotherapy in hepatocellular carcinoma: Insights from the IMbrave150 trial’ [Clin Mol Hepatol 2024;30:807-823]
Sun Young Yim, Sung Hwan Lee, Seung-Woo Baek, Bohwa Sohn, Yun Seong Jeong, Sang-Hee Kang, Kena Park, Hyewon Park, Sunyoung S. Lee, Ahmed O. Kaseb, Young Nyun Park, Sun-Hee Leem, Michael A. Curran, Ji Hoon Kim, Ju-Seog Lee
Clin Mol Hepatol. 2025;31(2):669-670.   Published online February 27, 2025
View: 1015   Download: 46
Correspondence
Correspondence to editorial on “Carvedilol to prevent hepatic decompensation of cirrhosis in patients with clinically significant portal hypertension stratified by new non-invasive model (CHESS2306)”
Chuan Liu, Ling Yang, Hong You, Gao-Jun Teng, Xiaolong Qi
Clin Mol Hepatol. 2025;31(2):e155-e157.   Published online August 30, 2024
View: 1163   Download: 46
Correspondence to letter to the editor on “Contemporary awareness of viral hepatitis between 2012 and 2022 among Korean adults”
Chang Hun Lee, In Hee Kim, Sook-Hyang Jeong
Clin Mol Hepatol. 2025;31(2):e149-e151.   Published online November 6, 2024
View: 928   Download: 19
Correspondence
Correspondence to editorial on “GOLM1 promotes cholesterol gallstone formation via ABCG5-mediated cholesterol efflux in MASH livers”
Yi-Tong Li, Wei-Qing Shao, Zhen-Mei Chen, Jing Lin, Jin-Hong Chen
Clin Mol Hepatol. 2025;31(2):e186-e188.   Published online January 24, 2025
View: 749   Download: 37  Web of Science: 1  Crossref: 1
Reply to Correspondence
Reply to correspondence on “Bariatric surgery reduces long-term mortality in patients with metabolic dysfunction-associated steatotic liver disease and cirrhosis”
Jing Zeng, Jian-Gao Fan
Clin Mol Hepatol. 2025;31(2):e218-e220.   Published online February 3, 2025
View: 770   Download: 27
Correspondence
Correspondence to editorial on “Targeting TM4SF1 promotes tumor senescence enhancing CD8+ T cell cytotoxic function in hepatocellular carcinoma”
Weifeng Zeng, Furong Liu, Yachong Liu, Zhanguo Zhang
Clin Mol Hepatol. 2025;31(2):e197-e199.   Published online February 5, 2025
View: 780   Download: 31
GOLM1 and bile acid synthesis: Correspondence to editorial on “GOLM1 promotes cholesterol gallstone formation via ABCG5-mediated cholesterol efflux in MASH livers”
Yi-Tong Li, Wei-Qing Shao, Zhen-Mei Chen, Jing Lin, Jin-Hong Chen
Clin Mol Hepatol. 2025;31(2):e189-e191.   Published online February 13, 2025
View: 752   Download: 30  Crossref: 1
Addressing the burden of steatotic liver disease: The role of transient elastography: Correspondence to editorial on “Current burden of steatotic liver disease and fibrosis among adults in the United States, 2017-2023”
Donghee Kim, Pojsakorn Danpanichkul, Karn Wijarnpreecha, George Cholankeril, Rohit Loomba, Aijaz Ahmed
Clin Mol Hepatol. 2025;31(2):e180-e182.   Published online February 13, 2025
View: 760   Download: 24
Reply to Correspondence
Reply to correspondence 1 on “GOLM1 promotes cholesterol gallstone formation via ABCG5-mediated cholesterol efflux in MASH livers”
Yoon-su Ha, Won Kim, Seung-Jin Kim
Clin Mol Hepatol. 2025;31(2):e226-e227.   Published online February 13, 2025
View: 1015   Download: 30
Correspondence
The burden of steatotic liver disease before and during the COVID-19 pandemic: Correspondence to editorial on “Current burden of steatotic liver disease and fibrosis among adults in the United States, 2017-2023”
Donghee Kim, Pojsakorn Danpanichkul, Karn Wijarnpreecha, George Cholankeril, Rohit Loomba, Aijaz Ahmed
Clin Mol Hepatol. 2025;31(2):e183-e185.   Published online February 17, 2025
View: 760   Download: 15  Crossref: 1
Correspondence to editorial on “Exploring methylation signatures for high de novo recurrence risk in hepatocellular carcinoma”
Kwang-Woong Lee, Young-Joon Kim
Clin Mol Hepatol. 2025;31(2):e206-e207.   Published online February 17, 2025
View: 725   Download: 24
Correspondence to editorial on “Global epidemiology of alcohol-related liver disease, liver cancer, and alcohol use disorder, 2000-2021”
Pojsakorn Danpanichkul, Luis Antonio Diaz, Kanokphong Suparan, Karn Wijarnpreecha, Juan Pablo Arab
Clin Mol Hepatol. 2025;31(2):e200-e202.   Published online February 17, 2025
View: 976   Download: 31
Correspondence to editorial on “Prediction of primary biliary cholangitis among health check-up population with anti-mitochondrial M2 antibody positive”
Haolong Li, Song Liu, Xu Wang, Li Wang, Tengda Xu, Yongzhe Li
Clin Mol Hepatol. 2025;31(2):e194-e196.   Published online February 24, 2025
View: 768   Download: 32
Correspondence to editorial on “Integrated molecular characterization of sarcomatoid hepatocellular carcinoma”
Rong-Qi Sun, Shao-Lai Zhou
Clin Mol Hepatol. 2025;31(2):e192-e193.   Published online February 26, 2025
View: 696   Download: 22
Reply to Correspondence
Reply to correspondence 2 on “GOLM1 promotes cholesterol gallstone formation via ABCG5-mediated cholesterol efflux in MASH livers”
Nahee Hwang, Sungsoon Fang
Clin Mol Hepatol. 2025;31(2):e228-e231.   Published online February 26, 2025
View: 810   Download: 25

Clinical and
Molecular
Hepatology

Print ISSN: 2287-2728
Online ISSN: 2287-285X

Editorial Office
The Korean Association for the Study of the Liver
Room A1210, 53 Mapo-daero(MapoTrapalace, Dowha-dong), Mapo-gu, Seoul, 04158, Korea
TEL: +82-2-703-0051   FAX: +82-2-703-0071    E-mail: cmh_journal@ijpnc.com
Copyright © The Korean Association for the Study of the Liver.         
COUNTER
TODAY : 1288
TOTAL : 2772788
Close layer